Related Experiment Video
Updated: Jun 13, 2025
08:20
Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
6.3K
Integration of computational models to predict botanical phytochemical constituent clearance routes by the Extended
Yitong Liu1, Michael Lawless2, Amy L Roe3
1Division of Toxicology, Office of Chemistry and Toxicology, Office of Laboratory Operations and Applied Science, Human Foods Program, U.S. Food and Drug Administration, Laurel, MD, USA.
Toxicology and Applied Pharmacology
|May 13, 2025
Summary
The Extended Clearance Classification System (ECCS) predicts how the body processes phytochemicals. Over half are metabolized by key enzymes, indicating potential drug interactions.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Phytochemical Analysis
- Computational Toxicology
Background:
- The Extended Clearance Classification System (ECCS) predicts chemical clearance routes.
- Quantitative structure-activity relationship (QSAR) models estimate physicochemical properties for ECCS predictions.
- Understanding botanical constituent clearance is crucial for safety evaluations.
Purpose of the Study:
- To apply the ECCS framework to evaluate phytochemical constituents.
- To predict metabolic and transport pathways for botanical compounds in humans.
- To assess potential interactions between phytochemicals and drugs.
Main Methods:
- Classified 82 phytochemical constituents into six ECCS classes using QSAR-predicted properties.
- Predicted drug-metabolizing enzyme (CYP450) and transporter interactions for constituents.
- Evaluated hepatic and renal clearance pathways based on ECCS classifications.
Main Results:
- Over 50% of phytochemicals were classified into ECCS class 2, primarily metabolized by CYP3A4, CYP2D6, and CYP1A2.
- More than 20% of constituents fell into ECCS class 4, predicted for renal clearance via glomerular filtration and active secretion.
- ECCS classes 1A and 2 showed high potential for CYP-mediated interactions; classes 3 and 4 had low renal transporter interaction potential.
Conclusions:
- The ECCS provides a data-driven framework for understanding botanical constituent clearance.
- Phytochemicals exhibit varied metabolic and renal clearance profiles, with significant potential for CYP interactions.
- This approach aids in contextualizing phytochemical data for improved safety assessments.
Related Concept Videos
01:09Clearance Models: Physiological Models
53
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
53
01:25Clearance Models: Compartment Models
56
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
56
01:17Clearance Models: Noncompartmental Models
46
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
46
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
68
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
68
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
34
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
34
01:14Hepatic Drug Clearance: Role of Transporters
44
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
44